IRIS Accounts Production v23.3.0.418 07551254 Board of Directors 1.6.22 31.5.23 31.5.23 0 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh075512542022-05-31075512542023-05-31075512542022-06-012023-05-31075512542021-05-31075512542021-06-012022-05-31075512542022-05-3107551254ns10:Originalns15:EnglandWales2022-06-012023-05-3107551254ns14:PoundSterlingns10:Original2022-06-012023-05-3107551254ns10:Originalns10:Director12022-06-012023-05-3107551254ns10:Original2022-06-012023-05-3107551254ns10:Original2023-05-3107551254ns10:Originalns10:CompanyLimitedByGuarantee2022-06-012023-05-3107551254ns10:Originalns10:SmallEntities2022-06-012023-05-3107551254ns10:Originalns10:AuditExempt-NoAccountantsReport2022-06-012023-05-3107551254ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-06-012023-05-3107551254ns10:SmallCompaniesRegimeForAccountsns10:Original2022-06-012023-05-3107551254ns10:Originalns10:FullAccounts2022-06-012023-05-3107551254ns10:Original2021-06-012022-05-3107551254ns10:Originalns10:Director22022-06-012023-05-3107551254ns10:Originalns10:Director32022-06-012023-05-3107551254ns10:Originalns10:Director42022-06-012023-05-3107551254ns10:Originalns10:Director52022-06-012023-05-3107551254ns10:Originalns10:RegisteredOffice2022-06-012023-05-3107551254ns10:Original2022-05-3107551254ns10:Originalns5:CurrentFinancialInstruments2023-05-3107551254ns10:Originalns5:CurrentFinancialInstruments2022-05-3107551254ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-05-3107551254ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-05-3107551254ns10:Originalns5:PlantMachinery2022-06-012023-05-3107551254ns10:Originalns5:PlantMachinery2022-05-3107551254ns10:Originalns5:PlantMachinery2023-05-3107551254ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-05-3107551254ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-05-31
REGISTERED NUMBER: 07551254 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MAY 2023

FOR

SOCIETY FOR ACUTE MEDICINE

SOCIETY FOR ACUTE MEDICINE (REGISTERED NUMBER: 07551254)






CONTENTS OF THE FINANCIAL STATEMENTS
For The Year Ended 31 May 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


SOCIETY FOR ACUTE MEDICINE

COMPANY INFORMATION
For The Year Ended 31 May 2023







DIRECTORS: Dr S Crossland
Dr T J Cooksley
Dr V A Price
Dr M J Wheble
Mr N R Murch





REGISTERED OFFICE: 75 Bournemouth Road
Chandlers Ford
Eastleigh
Hampshire
SO53 3AP





REGISTERED NUMBER: 07551254 (England and Wales)





ACCOUNTANTS: Stone Osmond Limited
75 Bournemouth Road
Chandlers Ford
Eastleigh
Hampshire
SO53 3AP

SOCIETY FOR ACUTE MEDICINE (REGISTERED NUMBER: 07551254)

BALANCE SHEET
31 May 2023

2023 2022
Notes £    £   
CURRENT ASSETS
Debtors 5 68,948 -
Prepayments and accrued income 11,943 53,261
Cash at bank 588,712 567,880
669,603 621,141
CREDITORS
Amounts falling due within one year 6 7,000 27,550
NET CURRENT ASSETS 662,603 593,591
TOTAL ASSETS LESS CURRENT
LIABILITIES

662,603

593,591

ACCRUALS AND DEFERRED INCOME 11,735 20,220
NET ASSETS 650,868 573,371

RESERVES
Income and expenditure account 650,868 573,371
650,868 573,371

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved and authorised for issue by the Board of Directors and authorised for issue on 26 September 2023 and were signed on its behalf by:





Dr M J Wheble - Director


SOCIETY FOR ACUTE MEDICINE (REGISTERED NUMBER: 07551254)

NOTES TO THE FINANCIAL STATEMENTS
For The Year Ended 31 May 2023

1. STATUTORY INFORMATION

Society For Acute Medicine is a private company, limited by guarantee , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents fees and other income from members and third parties.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - NIL).

SOCIETY FOR ACUTE MEDICINE (REGISTERED NUMBER: 07551254)

NOTES TO THE FINANCIAL STATEMENTS - continued
For The Year Ended 31 May 2023

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 June 2022
and 31 May 2023 1,586
DEPRECIATION
At 1 June 2022
and 31 May 2023 1,586
NET BOOK VALUE
At 31 May 2023 -

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Other debtors 68,948 -

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Other creditors 7,000 27,550

7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

During the year, the only transactions with directors were various reimbursement claims for travel and other expenses, which were paid on application.

8. ULTIMATE CONTROLLING PARTY

There is no controlling party or ultimate controlling party.

9. LIMITED BY GUARANTEE

Each and every member promises, if the Society is dissolved while he/she remains a member or within one year of ceasing to be a member, to pay up to £1 towards the payment of debts and liabilities incurred before they ceased to be a member and the payment of costs, charges and expenses of winding up.